By Felicia L. Pasadyn, MA
Peer Reviewed
Research demonstrates that less than 10% of physicians currently follow the United States Preventive Services Task Force (USPSTF) “B” recommendations for breast cancer prevention in nonpregnant …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
LATEST POSTS
The Original Bird Flu: Chlamydia psittaci
October 28, 2025
By Abigail Korenek
Peer Reviewed
Almost 100 years ago, a different kind of bird flu captured the public consciousness. Today, the media cycle is dominated by reports of highly pathogenic avian influenza in …
Cancer in an Immunocompromised Host
October 15, 2025
By Jacob Rozowsky
Peer Reviewed
As a medical student and researcher, I am fascinated by the mechanisms of evolution in human disease. I am particularly intrigued by oncology, where evolution unfolds in real-time. …
Brewing Beneath the Surface: The Link Between Psoriasis and Cardiovascular Disease
September 3, 2025
By Ipsita Subudhi
Peer Reviewed
When a patient comes in with skin plaques, bumps, and what might be a rash, the natural reaction might be to assume that these issues only …
Sleep for Sale: Can Commercial Wearable Sleep Technology Measure up Clinically?
August 5, 2025
By Emily Lock
Peer Reviewed
Sleep is a currency of wellness. Increased sleep duration has been associated with enhanced cognitive performance and decreased …
Forty Years of Prevention Guidance: The History and Processes of the United States Preventive Services Task Force
July 23, 2025
By Lydia Pan
Peer Reviewed
An ounce of prevention is worth a pound of cure. After all, it is far better to detect a serious illness before it develops its full harmful potential, …
How Can We Better Protect Our Patients Against Extreme Heat?
June 23, 2025
By Claire Young
Peer Reviewed
Last summer, New Yorkers experienced a heat wave1—causing infrastructure failures2,3, poor air quality, and even deaths. Summers are only getting …
Could Adults Without Diabetes Benefit from Continuous Glucose Monitoring?
May 22, 2025
By James Sun
Peer Reviewed
In March 2024, the FDA announced that it had cleared Dexcom Stelo, the first over-the-counter continuous glucose monitoring (CGM) system for adults without diabetes who want to understand better how diet and exercise affect their health (Figure …